VERICEL CORPORATION (VCEL) Debt Components
- 2018-09-30: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $13.18M; Line of Credit Facility, Remaining Borrowing CapacityUSD (m).
- 2018-06-30: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $14.42M; Line of Credit Facility, Remaining Borrowing CapacityUSD (m).
- 2018-03-31: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $15.65M; Line of Credit Facility, Remaining Borrowing CapacityUSD (m).
- 2017-12-31: Short-term DebtUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $16.89M; Line of Credit Facility, Remaining Borrowing CapacityUSD (m).
VERICEL CORPORATION Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Short-term Debt USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Line of Credit Facility, Remaining Borrowing Capacity USD |
|---|---|---|---|---|
| 2018-09-30 | (m) | (m) | $13.18M | (m) |
| 2018-06-30 | (m) | (m) | $14.42M | (m) |
| 2018-03-31 | (m) | (m) | $15.65M | (m) |
| 2017-12-31 | (m) | (m) | $16.89M | (m) |
| 2017-09-30 | (m) | (m) | $7.40M | (m) |
| 2017-06-30 | (m) | (m) | $8.04M | (m) |
| 2017-03-31 | (m) | (m) | $8.68M | (m) |
| 2016-12-31 | (m) | (m) | $9.32M | (m) |
| 2016-09-30 | (m) | (m) | $42.00K | (m) |
| 2016-06-30 | (m) | (m) | $52.00K | $7.20M |
| 2016-03-31 | (m) | (m) | $62.00K | $7.80M |
| 2015-12-31 | (m) | (m) | $71.00K | (m) |
| 2015-09-30 | (m) | (m) | $81.00K | (m) |
| 2015-06-30 | (m) | (m) | $91.00K | (m) |
| 2015-03-31 | (m) | (m) | $100.00K | (m) |
| 2014-12-31 | (m) | (m) | $109.00K | (m) |
| 2014-09-30 | (m) | $38.00K | $115.00K | (m) |
| 2014-06-30 | $2.50M | (m) | (m) | (m) |
| 2014-03-31 | (m) | $2.00K | (m) | (m) |
| 2013-12-31 | (m) | $6.00K | (m) | (m) |
| 2013-12-31 | $6.00K | (m) | (m) | (m) |
| 2013-09-30 | (m) | $10.00K | (m) | (m) |
| 2013-06-30 | (m) | $19.00K | (m) | (m) |
| 2013-03-31 | (m) | $27.00K | $2.00K | (m) |
| 2012-12-31 | (m) | $34.00K | $6.00K | (m) |
| 2012-09-30 | (m) | $40.00K | $9.00K | (m) |
| 2012-06-30 | (m) | $40.00K | $19.00K | (m) |
| 2012-03-31 | (m) | $40.00K | $29.00K | (m) |
| 2011-12-31 | (m) | $40.00K | $40.00K | (m) |
| 2011-09-30 | (m) | $51.00K | $49.00K | (m) |
| 2011-06-30 | (m) | $103.00K | $43.00K | (m) |
| 2010-12-31 | (m) | $214.00K | $41.00K | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |